全血输注的过去、现状与展望

doi:10.3969/j.issn.1671-2587.2024.04.022

临床输血与检验 ›› 2024, Vol. 26 ›› Issue (4): 563-569.DOI: 10.3969/j.issn.1671-2587.2024.04.022

全血输注的过去、现状与展望

张玲玲, 刘二雄, 刘志新, 安群星, 尹文

空军军医大学第一附属医院输血科,西安 710032

收稿日期:2024-07-07 出版日期:2024-08-20 发布日期:2024-09-23
通讯作者: 尹文,主要从事临床输血医学研究,（E-mail）yinwen@fmmu.edu.cn。
作者简介:张玲玲,主要从事血液病原学研究,（E-mail）sxkzhangll@163.com。

The Past, Present and Prospect of Whole Blood Transfusion

ZHANG Lingling, LIU Erxiong, LIU Zhixin, AN Qunxing, YIN Wen

Department of Transfusion Medicine, the First Affiliated Hospital of Air Force Military Medical University, Xi'an 710032

Received:2024-07-07 Online:2024-08-20 Published:2024-09-23

摘要/Abstract

摘要： 全血是有史以来最早使用的血液制品,但在20世纪70年代,随着成分输血治疗的出现,全血几乎从血库清单中消失了。近年来,在成功军事经验的基础上,全血用于出血性创伤患者复苏又重新引起了输血界的关注,并逐渐将其由军事领域引入到民用救治环境中。本文基于国内外全血输注指南以及发表的相关研究,就全血的分类、全血使用历史、全血储存及血小板保护、全血白细胞去除、全血病原灭活及科学精准输注全血亟待解决的问题等进行综述,展望其未来发展方向,为更广泛地重新认识引入全血,推动输血医学治疗的发展提供参考。

关键词: 全血, 低效价O型全血, 全血输注

Abstract: Whole blood was the earliest blood product ever used, however, with the advent of component transfusion treatments, whole blood all but disappeared from blood bank lists in the 1970 s. In recent years, based upon the successful military experience, the use of whole blood to resuscitate patients with hemorrhagic trauma has again attracted the attention of the blood transfusion circle,and it has gradually been introduced from the military field to the civilian treatment settings.Based on the guidelines for whole blood transfusion at home and abroad and related published studies, this paper reviews the classification of whole blood, history of whole blood use, whole blood storage and platelet protection, removal of whole blood white blood cells, inactivation of whole blood pathogens, and urgent problems to be solved in scientific and accurate transfusion of whole blood, and looks forward to its future development direction, providing reference for the introduction of whole blood more widely, and the development of blood transfusion medicine.

Key words: Whole blood, Low titer O whole blood, Whole blood transfusion

中图分类号:

R457.1

张玲玲, 刘二雄, 刘志新, 安群星, 尹文. 全血输注的过去、现状与展望[J]. 临床输血与检验, 2024, 26(4): 563-569.

ZHANG Lingling, LIU Erxiong, LIU Zhixin, AN Qunxing, YIN Wen. The Past, Present and Prospect of Whole Blood Transfusion[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(4): 563-569.

参考文献

[1] STRANDENES G,HERVIG T A,BJERKVIG C K,et al.The lost art of whole blood transfusion in austere environments[J]. Curr Sports Med Rep,2015,14(2):129-134.
[2] 何颖雨,刘磊. 低效价O型全血在紧急输血救治中的应用研究进展[J]. 联勤军事医学,2024,38(6):536-539.
[3] TORRES C M,KENT A,SCANTLING D,et al.Association of whole blood with survival among patients presenting with severe hemorrhage in US and Canadian adult civilian trauma centers[J]. JAMA Surg,2023,158(5):532-540.
[4] MYERS J C,BRAVERMAN M A,CIARAGLIA A,et al.Risk factors for massive transfusion in obstetrical hemorrhage and consideration of a whole blood program[J]. Transfusion,2023,63(Suppl 3): S112-S119.
[5] 中华人民共和国国家卫生健康委员会.全血和成分血使用[S]. 2018.
[6] 王政军,张玉龙,周欠欠,等. 全血在应急输血救治中的应用进展[J]. 中国输血杂志,2019,32(6):598-602.
[7] HALEY N R,HESS J R.Whole blood:back to the future[J]. Transfusion,2019,59(11):3293-3294.
[8] SPINELLA P C.Warm fresh whole blood transfusion for severe hemorrhage:U.S. military and potential civilian applications[J]. Crit Care Med,2008,36(7 Suppl):S340-S345.
[9] DUMONT L J,AUBUCHON J P.Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials[J]. Transfusion,2008,48(6):1053-1060.
[10] MOORE G L,PECK C C,SOHMER P R,et al.Some properties of blood stored in anticoagulant CPDA-1 solution. A brief summary[J]. Transfusion,1981,21(2):135-137.
[11] YAZER M H,CAP A P,SPINELLA P C,et al.How do I implement a whole blood program for massively bleeding patients?[J]. Transfusion,2018,58(3):622-628.
[12] HUISH S,GREEN L,CURNOW E,et al.Effect of storage of plasma in the presence of red blood cells and platelets:re-evaluating the shelf life of whole blood[J]. Transfusion,2019,59(11):3468-3477.
[13] JOBES D,WOLFE Y,O’NEILL D,et al. Toward a definition of “fresh” whole blood:an in vitro characterization of coagulation properties in refrigerated whole blood for transfusion[J]. Transfusion,2011,51(1):43-51.
[14] REDDOCH K M,PIDCOKE H F,MONTGOMERY R K,et al. Hemostatic function of apheresis platelets stored at 4 ℃ and 22 ℃[J]. Shock,2014,41 Suppl 1(0 1):54-61.
[15] SKRIPCHENKO A,MYRUP A,THOMPSON-MONTGOMERY D,et al.Periods without agitation diminish platelet mitochondrial function during storage[J]. Transfusion,2010,50(2):390-399.
[16] HOSSEINI E,SOLOUKI A,HAGHSHENAS M,et al.Agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage[J]. Thromb J,2022,20(1):3.
[17] 马兴焕. 冷藏全血中血小板质量评价及全血骨内输注安全性研究[D]. 郑州:郑州大学,2022.
[18] SLICHTER S J,FITZPATRICK L,OSBORNE B, et al.Platelets stored in whole blood at 4 ℃:in vivo posttransfusion platelet recoveries and survivals and in vitro hemostatic function[J]. Transfusion,2019,59(6): 2084-2092.
[19] U.S.Food and Drug Administration. Guidance for Industry:alternative procedures for the manufacture of cold-stored platelets intended for the treatment of active bleeding when conventional platelets are not available or their use is not practical[R/OL]. (2023-06-23)[2023-10-09]. https://www.fda.gov/regulatory- information/search-fda-guidance-documents/alternative-procedures-manufacture-cold-stored-platelets-intended-treatment-active-bleeding-when.
[20] 王鸿捷,郭永建. 美国FDA冷藏血小板生产替代程序指引主要内容及其启示[J]. 中国输血杂志,2023,36(11):1079-1084.
[21] SCHMIDT P J.The plasma wars:a history[J]. Transfusion,2012,52(Suppl 1):2S-4S.
[22] HERVIG T A,DOUGHTY H A,CARDIGAN R A,et al.Re-introducing whole blood for transfusion:considerations for blood providers[J]. Vox Sang,2021,116(2):167-174.
[23] MO Y D,JACQUOT C.Transfusion therapy: evidence and recommendations for clinical practice[M]//COHN C S,DELANEY M,JOHNSON S T,et al.AABB Technical Manual.21st ed.Bethesda: AABB,2023: 589-611.
[24] 陈翔宇,刘红升,向强,等.创伤失血性休克中国急诊专家共识(2023)[J].中国急救医学,2023,43(11):841-854.
[25] ESPINOSA A,DYBVIK B,MEDBY C,et al.Implementation of a protocol for prehospital transfusion of low-titer,leukocyte-depleted whole blood for civilian bleeding patients[J]. Transfus Apher Sci,2019,58(2):212-215.
[26] SPINELLA P C,PIDCOKE H F,STRANDENES G,et al.Whole blood for hemostatic resuscitation of major
bleeding[J]. Transfusion,2016,56(Suppl 2):S190-S202.
[27] SOLHEIM B G,FLESLAND O,BROSSTAD F,et al.Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole blood[J]. Transfus Apher Sci,2003,29(2):133-139.
[28] SPINELLA P C,PERKINS J G,GRATHWOHL K W, et al.Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries[J]. J Trauma,2009, 66(4 Suppl):S69-S76.
[29] MCGILL M,BRINDLEY D C.Effects of storage on platelet reactivity to arterial subendothelium during blood flow[J]. J Lab Clin Med,1979,94(2):370-380.
[30] KOGLER V J,MILES J A,ÖZPOLAT T,et al.Platelet dysfunction reversal with cold-stored vs room temperature-stored platelet transfusions[J]. Blood,2024,143(20):2073-2088.
[31] CARRICO C J,CANIZARO P C,SHIRES G T.Fluid resuscitation following injury:rationale for the use of balanced salt solutions[J]. Crit Care Med,1976,4(2):46-54.
[32] COTTON B A,GUY J S,MORRIS J A Jr,et al. The cellular,metabolic,and systemic consequences of aggressive fluid resuscitation strategies[J]. Shock,2006,26(2):115-121.
[33] DEATON T G,AUTEN J D,BETZOLD R,et al.Fluid resuscitation in tactical combat casualty care;TCCC guidelines change 21-01.4 November 2021[J]. J Spec Oper Med,2021,21(4):126-137.
[34] SEHEULT J N,BAHR M P,SPINELLA P C,et al.The Dead Sea needs salt water… massively bleeding patients need whole blood:The evolution of blood product resuscitation[J]. Transfus Clin Biol,2019,26(3):174-179.
[35] BJERKVIG C K,STRANDENES G,HERVIG T,et al.Prehospital whole blood transfusion programs in Norway[J]. Transfus Med Hemother,2021,48(6):324-331.
[36] MUNOZ J L,KIMURA A M,XENAKIS E,et al.Whole blood transfusion reduces overall component transfusion in cases of placenta accreta spectrum:a pilot program[J]. 2022,35(25):6455-6460.
[37] NGATUVAI M,ZAGALES I,SAUDER M,et al.Outcomes of transfusion with whole blood,component therapy,or both in adult civilian trauma patients:a systematic review and meta-analysis[J]. J Surg Res,2023,287:193-201.
[38] GAINES B A,YAZER M H,TRIULZI D J,et al.Low titer group O whole blood in injured children requiring massive transfusion[J]. Ann Surg,2023,277(4):e919-e924.
[39] HANNA M,KNITTEL J,GILLIHAN J.The use of whole blood transfusion in trauma[J]. Curr Anesthesiol Rep,2022,12(2):234-239.
[40] WALSH M,FRIES D,MOORE E,et al.Whole blood for civilian urban trauma resuscitation:historical, present,and future considerations[J]. Semin Thromb Hemost,2020,46(2):221-234.
[41] AVERY P,MORTON S,TUCKER H,et al.Whole blood transfusion versus component therapy in adult trauma patients with acute major haemorrhage[J]. Emerg Med J, 2020,37(6):370-378.
[42] RUBY K N,DZIK W H,COLLINS J J,et al.Emergency transfusion with whole blood versus packed red blood cells:a study of 1400 patients[J]. Transfusion,2023, 63(4):745-754.
[43] 罗圆圆,马春娅,刘丽,等. 基于低效价O型全血及A型血浆建立战备血库的可行性分析[J]. 中国实验血液学杂志, 2024,32(2):541-545.
[44] 邓跃林. 中毒救治的新思路——全血置换[C]//中国毒理学会.2018全国中毒救治首都论坛-暨第十届全国中毒及危重症救治学术研讨会论文集.中南大学湘雅医院;2018:8.
[45] 唐聪海,林达义,林艺璇,等. 左氧氟沙星诱导急性溶血性贫血的诊治——附1例报告[J]. 中国输血杂志,2021, 34(4):392-395.
[46] HARM S K,YAZER M H,BUB C B,et al.Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma,apheresis platelet,and whole blood units tested by different methods[J]. Transfusion, 2019,59(2):762-767.
[47] SPROGØE U,YAZER M H,RASMUSSEN M H,et al. Minimal variation in anti-A and-B titers among healthy volunteers over time:Implications for the use of out-of-group blood components[J]. J Trauma Acute Care Surg,2017,82(6S Suppl 1): S87-S90.
[48] ASSING K,SPROGOE U,NIELSEN C,et al.Increased but stable isoagglutinin titers in hemodialysis patients[J]. J Nephrol,2019,32(1):121-127.
[49] BAILEY J D,FISHER A D,YAZER M H,et al.Changes in donor antibody titer levels over time in a military group O low-titer whole blood program[J]. Transfusion,2019,59(S2):1499-1506.
[50] REBULLA P.The long and winding road to pathogen reduction of platelets,red blood cells and whole blood[J]. Br J Haematol,2019,186(5):655-667.

全血输注的过去、现状与展望

The Past, Present and Prospect of Whole Blood Transfusion

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	张雷英, 于洋. ABO不同型血浆输注的风险认知与临床实践进展[J]. 临床输血与检验, 2024, 26(2): 164-172.
[2]	郭天虹, 王雨涵, Claudia SC, 黄远帅. 基于研究证据的输血医学新进展[J]. 临床输血与检验, 2023, 25(4): 572-576.
[3]	张嘉英, 樊斌, 朱立国, 汪德清, 李捷. 核黄素光化学法处理对全血中淋巴细胞功能的影响[J]. 临床输血与检验, 2020, 22(6): 599-602.
[4]	傅钰斌, 汪传喜, 张伟东, 李仲平, 黄杰庭, 汤静儿. 不同检测模式下无偿献血者血液标本检测不合格情况对照分析^*[J]. 临床输血与检验, 2019, 21(2): 159-161.
[5]	李丽玮, 杨燕, 钟宁, 于建, 李兴龙, 李志强. 气动管道系统对全血部分血细胞相关功能参数影响^*[J]. 临床输血与检验, 2019, 21(1): 6-8.
[6]	于建, 李兴龙, 杨燕, 钟宁, 李丽玮, 李志强. 气动管道系统对全血血浆凝血因子与生化参数的影响^*[J]. 临床输血与检验, 2019, 21(1): 8-10.
[7]	钟宁, 李丽玮, 于建, 杨燕, 李兴龙, 李志强. 气动管道系统对全血血细胞部分参数的影响^*[J]. 临床输血与检验, 2019, 21(1): 16-19.